Paragon Bioservices Appoints Quality VP

Deborah Wild has been appointed vice president, Quality and Regulatory Affairs, Paragon Bioservices, where she will focus on accelerating the company’s quality agenda.

Ms. Wild is a Quality Executive/Leader with 30 years of experience. Most recently she ran a consulting practice leading Quality Assurance focused initiatives for clients such as Genentech, Teva, Polynoma, Cytovance, and CMC Biologics.  Ms. Wild also held roles at Polynoma as vice president of Quality Systems and vice president of manufacturing and Supply Chain at Victory Pharma.  Prior to launching her practice, she spent more than 17 years at Genentech ending there as director of Contract Manufacturing. 

"We are building a world class team and Ms. Wild's experience and leadership is spot on to support Paragon's growth initiatives in GMP vaccine and viral vector manufacturing," said Peter Buzy, president and chief executive officer of Paragon. "Having both quality and manufacturing experience, Deb has a strong track record of executing plans that have added the profitability for the companies she has been employed by, both as an employee and as a consultant. We are excited to have Deborah join our senior team and to be a critical part of the Company's future growth.  We look forward to her contributions as we continue to grow the company."